Robert J. Israel, Senior VP Medical Affairs at PROGENICS PHARMACEUTICALS INC (PGNX), sold 5,000 shares at $6.33 ($32K) on 2013-07-18, disclosed to the SEC on 2013-07-22.
Scheduled sale ($32k) by Senior VP Medical Affairs under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| PGNX | SELL | 2015-03-13 | $14K | — | Filing → |
| PGNX | SELL | 2015-03-04 | $32K | — | Filing → |
| PGNX | SELL | 2015-01-13 | $14K | — | Filing → |